Pharmac has decided to disestablish its Māori advisory group - something the advisory group’s former chairman says will ...

Pharmac is funding new medicine for people with attention deficit hyperactivity disorder (ADHD) and narcolepsy, and removing ...

The testing kit confirms a pregnancy has ended following a medical abortion.

From 1 December 2024, Pharmac is also removing the renewal criteria for methylphenidate, dexamfetamine and modafinil, medicines used to treat ADHD and narcolepsy. This means that once an initial ...

Pharmac only established Te Rōpū in 2021 after a damning independent review of the agency and health outcomes for Māori, ...

Advocacy group Aroreretini Aotearoa, says the changes will improve productivity for the ADHD community, by almost 57-million-dollars. Chief medical officer David Hughes says it will streamline ...

Pharmac is funding Lisdexamfetamine for ADHD and narcolepsy, benefiting more than 6000 people from December. Pharmac is ...

Pharmac has decided to fund an at-home low sensitivity test kit that confirms a pregnancy has ended following a medical abortion. The urine test kit (branded as CheckToP) detects the levels of ...

MSNZ president Neil Woodhams said the wider financial impacts of MS on people and families needed to be recognised in Pharmac's funding decisions. "Somebody might have Multiple Sclerosis for 30 or ...

By AUT Journalism Student Vivek Panchal The Government has announced it will increase funding for Pharmac, boosting ...

She says having another option out there means we're not so dependent on patches anymore, which is good news for a lot of ...

A range of approaches is needed to manage mental health presentations. In this article, specialist GP Sophie Jadwiga Ball ...